Idrasil™ provides all of the medicinal analgesic & therapeutic benefits of Medical Cannabis without the social risks associated with smoking or the unpredictable dosages of edible confections. Idrasil™ eliminates the negative social stigmas associated with Medical Marijuana and replaces them with a mainstream ALL NATURAL NUTRACEUTICAL which looks like any other pill on the market.
Medical Cannabis in general and Idrasil™ specifically, have been identified to be a beneficial treatment reflected through studies and science for numerous medical ailments and conditions. With all the research that is coming out every day, it can be hard to keep up with all the latest information. Below you will find a list of numerous medical conditions and by clicking on the specific ailment you will find more specific information about how Idrasil™ (Medical Cannabis) can help.
Talking with your doctor about how medical cannabis can be part of your overall treatment plan can seem intimidating. The best way to approach your physician is from a position of knowledge. Learn what protections physicians really have so you can inform them and help them understand its legal and ethical for them to recommend cannabis as a treatment option for their qualifying patients.
Physicians have countless hours of training in a wide variety of areas, but many are unfamiliar with current research that supports the recommendation of medical cannabis as part of a comprehensive treatment plan for many debilitating medical conditions and their treatments. We have provided you with this information so you can discuss cannabis with your doctor from an informed perspective.
C3® International, Inc. is here to help. This website contains information to help you through this process. Whether you are a seeking relief for chronic pain, are looking to transition from synthetic medications, or just learning about the benefits of cannabinoids we are here to assist you.
Yes. “Scientific data indicate the potential therapeutic value of cannabinoid drugs, primarily THC, for pain relief, control of nausea and vomiting, and appetite stimulation;…” – Institute of Medicine, Marijuana, and Medicine: Assessing the Science Base, 1999.
Medical Cannabis has demonstrated efficacy in treating the symptoms of a wide range of diseases including:
Cancer • AIDS/HIV • Alzheimer’s • Multiple Sclerosis • Chrohn’s Disease • Intractable Neuropathic and Chronic Pain
Medical cannabis’s synergistic effects with other drugs allow patients to use lower doses of opiate pain relievers.
Unlike the so-called marijuana pill, Marinol, the whole plant contains all 70 cannabinoids shown to have health benefits, not just one – THC. It is less expensive and dosages are easier to control.
Yes. There are numerous studies demonstrating medical cannabis’s safety and efficacy. There is no known lethal dose of cannabis or any documented case of anyone ever dying from marijuana overdose or allergic reaction. Even common aspirin causes over 1,000 American deaths annually.
In 1988. the DEA’s Chief Administrative judge, Francis Young, after an exhaustive hearing stretching over many months and hundreds of pages of testimony from patients, health care providers, addictions specialists and law enforcement officers concluded the following:
“The cannabis plant considered as a whole has a currently accepted medical use in treatment in the United States, there is no lack of accepted safety for use under medical supervision…”
Yes. The 9th U.S. Circuit Court of Appeals ruled that doctors may discuss medical cannabis with their patients and may issue written recommendations for its use as part of a comprehensive treatment plan – Conant v. Walters, 309 F.3d 629 (2002). When this ruling was appealed again, the U.S. Supreme Court refused to hear the case, allowing the decision to stand. It is also the current federal policy not to prosecute medical marijuana cases where no state laws are being violated. Compassionate doctors in California need not fear to lose their federal license to dispense controlled substances.
Idrasil™ can be used to treat a variety of Clinically EndoCannabinoid Deficient (CECD) conditions as they relate to
DISCLAIMER: THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. FURTHERMORE, NONE OF THE INFORMATION ON THIS PAGE SHOULD BE USED AS A SUBSTITUTE FOR THE ADVICE OF AN APPROPRIATELY QUALIFIED PHYSICIAN OR OTHER HEALTHCARE PROVIDER. THIS INFORMATION IS ONLY MEANT FOR INFORMATIONAL PURPOSES.
© 2025 IdrasilTM a product of CS® International, Inc. - All rights Reserved.